SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Tonix Pharmaceuticals announced positive feedback for the design of an adaptive Phase 2 Lyme disease study of TNX-4800, with plans to begin the trial in early 2027. The long-acting…
Krystal Bio reported $119.2M in VYJUVEK revenue for Q2 2026, showcasing growing commercial traction. Maintaining a $1.1B cash balance, the company is on track for launches in Spain…
The company announced full enrollment in its BUOY-1 Phase 2b trial of GlyphAllo for MDD and shared financial highlights, advancing its pipeline of neuropsychiatric therapies.
D-Wave Quantum announced a collaboration with Nasdaq Verafin to evaluate quantum-hybrid technology for improving predictive systems in financial crime detection, potentially enhanc…
Autolus issued a warrant certificate for up to 3.5 million ADSs to Perceptive Credit Holdings, as a loan condition. The securities are unregistered.
Bioxcel Therapeutics, Inc. and its lenders amended the Existing Credit Agreement dated April 19, 2022, subject to the satisfaction of certain conditions precedent, as set forth in …
CPHC announced the acquisition of The Advocacy Partners for an immediately earnings accretive price. The deal creates a national footprint in state-level government relations and l…
Marriott International, Inc. reported strong Q2 2026 results with global RevPAR increasing 3.4% year-over-year due to solid demand in the U.S. & Canada, while the company raised it…
Institutional holdings report (13F-HR) filed by Rising Stella Capital Pte. Ltd.
Southern Company announced a private placement of $650M and $1.5B in convertible senior notes, targeting qualified institutional buyers. This financing activity impacts the company…
Indivior posted record quarterly net revenues and raised 2026 full-year guidance driven by strong SUBLOCADE performance. The company also announced a merger agreement with Supernus…
Supernus Pharmaceuticals reported a strong revenue increase, raising its full-year guidance and agreeing to merge with Indivior to enhance its CNS portfolio.
The REIT reported net income of $3.2 million in Q2 2026 and plans to raise 2026 guidance. It also closed a new $200 million senior unsecured term loan facility with an accordion op…
Supernus Pharmaceuticals and Indivior Pharmaceuticals have entered into a definitive merger agreement under which Supernus will acquire Indivior. The agreement was reached to combi…
Institutional holdings report (13F-HR) filed by OPTIMAS CAPITAL Ltd.
Indivior Pharmaceuticals, Inc. has entered into an agreement and plan of merger with Supernus Pharmaceuticals, Inc., marking a strategic acquisition to expand its product portfolio…
Kosmos Energy reported Q2 2026 net income of $185 million and an 12% increase in net production to roughly 71,400 boepd, while completing a farm-down of the Tiberius project and re…
CNH Industrial reported $4.8 billion in revenues and $141 million in net income. The company returned $0.2 billion to shareholders. Despite a soft agriculture market, the company a…
American Bitcoin reported a record 932 Bitcoin mined and grew its strategic reserve to over 8,000. The company recorded $67.0 million in mining revenue as Bitcoin price volatility …
Integer Holdings reported a 2.6% decline in second-quarter sales to $464 million. Concurrently, the company announced a definitive agreement to be acquired by an affiliate of KKR i…